| Karoly Andrew Vollmer, DO | |
|
270 Park Ave, Huntington, NY 11743-2787 | |
| (718) 960-9447 | |
| Not Available |
| Full Name | Karoly Andrew Vollmer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 270 Park Ave, Huntington, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205213212 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 303626 (New York) | Primary |
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Sagent Pharmaceuticals, Inc. today announced that it has closed its previously announced initial public offering of 5,750,000 shares of its common stock at a price to the public of $16.00 per share.
Almost 12,000 people died in alcohol-related vehicle crashes in 2008. About 15,000 Americans died of AIDS-related illness the same year. Both of these preventable causes of death have been the subject of massive, expensive and high-profile interventions by federal and state authorities. CRE encourages expenditures for these programs but the public health community should be even more concerned for greater society-wide risks.
Obesity was associated with a shorter lifespan and an increased risk of illness and death from cardiovascular disease, and being overweight was associated with a lifespan similar to be being normal weight but a higher risk of developing cardiovascular disease younger.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.
Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karoly Andrew Vollmer, DO 270 Park Ave, Huntington, NY 11743-2787 Ph: (718) 960-9447 | Karoly Andrew Vollmer, DO 270 Park Ave, Huntington, NY 11743-2787 Ph: (718) 960-9447 |
News Archive
Sagent Pharmaceuticals, Inc. today announced that it has closed its previously announced initial public offering of 5,750,000 shares of its common stock at a price to the public of $16.00 per share.
Almost 12,000 people died in alcohol-related vehicle crashes in 2008. About 15,000 Americans died of AIDS-related illness the same year. Both of these preventable causes of death have been the subject of massive, expensive and high-profile interventions by federal and state authorities. CRE encourages expenditures for these programs but the public health community should be even more concerned for greater society-wide risks.
Obesity was associated with a shorter lifespan and an increased risk of illness and death from cardiovascular disease, and being overweight was associated with a lifespan similar to be being normal weight but a higher risk of developing cardiovascular disease younger.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.
Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch."
› Verified 4 days ago
Dr. Raul Fernando, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2000 | |
Dr. Susan E Esposito, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-651-8370 | |
Dr. Pedram Bagheri, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 270 Park Ave, Huntington Hospital Deparment Of Emergency Medicine, Huntington, NY 11743 Phone: 631-351-2000 Fax: 631-351-2586 | |
Ellen Marie Menocal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2000 | |
Dr. Neil T Moskowitz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2000 | |
Jeff Cheung, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-547-6392 | |
Dr. Adam H Litroff, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 270 Park Ave, Huntington Hospital, Dept Of Emergency Medicine, Huntington, NY 11743 Phone: 631-351-2300 |